ferrous oxide has been researched along with daunorubicin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, BA; Chen, YH; Lai, BB; Lu, Q; Wang, XM; Zhang, G; Zhou, YY | 1 |
1 other study(ies) available for ferrous oxide and daunorubicin
Article | Year |
---|---|
Fe3O4 nanoparticles with daunorubicin induce apoptosis through caspase 8-PARP pathway and inhibit K562 leukemia cell-induced tumor growth in vivo.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Caspase 8; Daunorubicin; Doxorubicin; Drug Delivery Systems; Female; Ferrous Compounds; Humans; K562 Cells; Magnetite Nanoparticles; Metabolic Networks and Pathways; Mice; Mice, Nude; Poly(ADP-ribose) Polymerases | 2011 |